1 / 8

Quantitative Analysis of the Current Early Toxicity Testing Market Trends

The market estimations provided in the report are based on comprehensive analysis of the key developments in the industry.The global early toxicity testing market is comprehensively analyzed with respect to technique, end users, and geography.<br>

srushtih123
Download Presentation

Quantitative Analysis of the Current Early Toxicity Testing Market Trends

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Opportunity Analysis and Industry Forecast, 2016-2023 Early Toxicity Testing Market Global Opportunity Analysis and Industry Forecast, 2014-2022

  2. Early Toxicity Testing Market The drug failures in later stages of drug testing due to the toxicity issues have led to heavy financial losses to the companies. This is leading to the increased awareness and adoption of early toxicity testing to avoid such possible financial losses in future.

  3. Early Toxicity Testing Market Overview Early Toxicity Testing Market accounted for $614 million in 2015 and is anticipated to reach $1,012 million by 2022, registering a CAGR of 7.3% during the forecast period, 2016 to 2022, according to a new report published by Allied Market Research. Among different geographic regions, Europe is the largest contributor toward the early toxicity testing market; whereas, Asia-Pacific is the fastest growing region. Access Full Summary at : https://www.alliedmarketresearch.com/early-toxicity-testing-market Early toxicity testing is used during clinical trials, where the toxicity of the compounds present in the test product is evaluated. Different tests are conducted to check the adverse effects of the compound on different aspects of human health. Some tests are also useful to check if the entity has toxic potentials such as genotoxicity, carcinogenicity, neurotoxicity, and systemic toxicity. These toxicity tests are important for the welfare of human health and environment.

  4. Early Toxicity Testing Market The global early toxicity testing market is segmented based on technique, end users, and geography. Based on technique, the market is categorized into in vivo, in vitro, and in silico. Based on the type of assay used, in vitro technique is further divided into enzyme toxicity assays, bacterial toxicity assays, cell-based ELISA and western blots, tissues culture assays, receptor binding assays, and other assays. Based on the toxicity end-points, in vitro technique is further segmented into dermal toxicity, systemic toxicity, carcinogenicity, ocular toxicity, skin sensitization and irritation, genotoxicity, neurotoxicity, organ toxicity, and other toxicity endpoints. The market is expected to witness moderate growth during the forecast period, owing to the increase in awareness of the regulatory authorities concerning environment and public health welfare. In addition, replacement of in vivo models with in vitro models and technological advancement in the in vitro and in vivo technique supplement the market growth. As early toxicity tests can help reduce the risk of drug failure in later stages, there is a rise in the demand for early toxicity tests. 

  5. Early Toxicity Testing Market, Snapshot The early toxicity testing market is growing at a steady pace due to the increase in stringency of regulatory authorities regarding environment and public welfare. Furthermore, the use of early toxicity tests reduce the risks of drug failure in later stages of drug development, thus preventing heavy financial losses of the companies. This has led to the growth in the investment for R&D of toxicity testing techniques and emergence of new models & tests to evaluate the toxicity of the substance. For instance, on July 2016, Cyprotex PLC launched an in vitro 3D cellular model that could be used to evaluate cardiotoxicity. The key players profiled in this report include Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., Agilent Technologies Inc., Quest Diagnostics Incorporation, Merck & Co., Inc., Charles River Laboratories International Incorporation, Becton, Dickinson And Company, Danaher Corporation, Evotec Ag, and The Jackson Laboratory. There are other players in the early toxicity testing market which include Covance, CellSystems, BioQuanta, Epithelix, CeltherPolska, and HemoGenix.

  6. Early Toxicity Testing MarketKey Benefits • This report entails detailed quantitative analysis of the current market trends for the period of 2014-2022 to identify the prevailing opportunities. • The market estimations provided in the report are based on comprehensive analysis of the key developments in the industry. • The global early toxicity testing market is comprehensively analyzed with respect to technique, end users, and geography. • In-depth analysis based on geography helps understand the regional market to assist in strategic business planning. • The development strategies adopted by key manufacturers are enlisted in the report to understand the competitive scenario of the market.  

  7. Early Toxicity Testing MarketBy Geography North America Europe Asia-Pacific LAMEA

  8. Early Toxicity Testing Market Thank You! For More Details Visit us at https://www.alliedmarketresearch.com/request-sample/619 Follow Us On

More Related